Patent · US Active

Procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line

US8288109B2 · kind B2 · utility

1Cited by
9References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 20, 2005
Grant dateOct 16, 2012
Priority date
Expiry dateJul 2, 2026

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/6803
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention provides a structural characterization platform that can be used to assess the stability of a polyclonal cell line during production, as well as batch-to-batch consistency of the final polyclonal products. The structural characterization platform is based on genetic analyses as well as protein characterization techniques that alone or in combination provide the necessary information to characterize the polyclonal cell line and final products. The collection of different homologous proteins to be analyzed with the platform techniques if for example a recombinant polyclonal antibody or a mixture of monoclonal antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.